Adeno-associated virus 2 (AAV), a nonpathogenic human parvovirus, requires co-infection with a helper virus for its optimal replication. Although AAV possesses a broad host range, certain cell types lack the machinery necessary for efficient entry into the cell and intracellular trafficking of AAV into the nucleus, where the viral second-strand DNA synthesis must occur before gene expression. We have demonstrated that in less-permissive mouse fibroblasts, the virus fails to transport to the nucleus due to altered endocytic processing. However, relatively little is known about the intracellular site of viral uncoating and transport of the virion across the nuclear envelope. Here, we provide evidence that AAV can efficiently enter intact nucl...
Adeno-associated virus (AAV) is gaining momentum as a gene therapy vector for human applications. Ho...
We examined cytoplasmic trafficking and nuclear translocation of adeno-associated virus type 2 (AAV)...
Adeno-associated virus (AAV) is gaining momentum as a gene therapy vector for human applications. Ho...
Understanding adeno-associated virus (AAV) trafficking is critical to advance our knowledge of AAV b...
Understanding adeno-associated virus (AAV) trafficking is critical to advance our knowledge of AAV b...
Understanding adeno-associated virus (AAV) trafficking is critical to advance our knowledge of AAV b...
Adeno-associated virus (AAV) serotypes are being tailored for numerous therapeutic applications, but...
We have investigated the infectious entry pathway of adeno-associated virus (AAV) and recombinant AA...
We have investigated the infectious entry pathway of adeno-associated virus (AAV) and recombinant AA...
Adeno-associated virus (AAV) serotypes are being tailored for numerous therapeutic applications, but...
Recombinant adeno-associated viral (rAAV) vectors have garnered much promise in gene therapy applica...
Recombinant adeno-associated viral (rAAV) vectors have garnered much promise in gene therapy applica...
Adeno-associated virus (AAV) is an attractive vehicle for gene therapy. Serotypes of this non-pathog...
Adeno-associated virus (AAV) is a defective and non-pathogenic human parvovirus that is dependent on...
Adenoviruses enter their host cells by receptor-mediated endocytosis and acid-activated penetration ...
Adeno-associated virus (AAV) is gaining momentum as a gene therapy vector for human applications. Ho...
We examined cytoplasmic trafficking and nuclear translocation of adeno-associated virus type 2 (AAV)...
Adeno-associated virus (AAV) is gaining momentum as a gene therapy vector for human applications. Ho...
Understanding adeno-associated virus (AAV) trafficking is critical to advance our knowledge of AAV b...
Understanding adeno-associated virus (AAV) trafficking is critical to advance our knowledge of AAV b...
Understanding adeno-associated virus (AAV) trafficking is critical to advance our knowledge of AAV b...
Adeno-associated virus (AAV) serotypes are being tailored for numerous therapeutic applications, but...
We have investigated the infectious entry pathway of adeno-associated virus (AAV) and recombinant AA...
We have investigated the infectious entry pathway of adeno-associated virus (AAV) and recombinant AA...
Adeno-associated virus (AAV) serotypes are being tailored for numerous therapeutic applications, but...
Recombinant adeno-associated viral (rAAV) vectors have garnered much promise in gene therapy applica...
Recombinant adeno-associated viral (rAAV) vectors have garnered much promise in gene therapy applica...
Adeno-associated virus (AAV) is an attractive vehicle for gene therapy. Serotypes of this non-pathog...
Adeno-associated virus (AAV) is a defective and non-pathogenic human parvovirus that is dependent on...
Adenoviruses enter their host cells by receptor-mediated endocytosis and acid-activated penetration ...
Adeno-associated virus (AAV) is gaining momentum as a gene therapy vector for human applications. Ho...
We examined cytoplasmic trafficking and nuclear translocation of adeno-associated virus type 2 (AAV)...
Adeno-associated virus (AAV) is gaining momentum as a gene therapy vector for human applications. Ho...